VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept

• Status: Completed
• Trial end date: 2010-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of the study is to investigate how effective VA111913 is at preventing menstrual pain in women with primary dysmenorrhoea.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vantia Ltd

Criteria

Inclusion Criteria:

• Women between 18 and 35 years old

• Not pregnant

• History of primary dysmenorrhoea

• Regular menstrual cycles

• Signed informed consent

Exclusion Criteria:

• Known secondary dysmenorrhoea

• Concomitant use of regular prescription or non prescription medications or herbal remedies

• Any clinically significant medical history or active disease

• Participation in another clinical study in the last 3 months

• Contraindication to chosen rescue medications or allergy to their constituents

• Other protocol defined eligibility criteria may apply